1 | vs | 40,765 |
2 | plus/minus | 20 |
3 | ─ | 20 |
4 | /bpo | 16 |
5 | -bpo | 13 |
6 | -bupivacaine | 9 |
7 | /moxidectin | 5 |
8 | lidocaine-medicated | 5 |
9 | -box | 3 |
10 | mg→15 | 3 |
11 | -1,3-oxazin-4-one | 2 |
12 | -inadequate | 2 |
13 | -v- | 2 |
14 | /flumethrin | 2 |
15 | 0.73- | 2 |
16 | aquilion | 2 |
17 | female/ | 2 |
18 | pyrimidin- | 2 |
19 | 'christoph | 1 |
20 | ,13/ | 1 |
21 | -2-p-tolyloxy-quinoline | 1 |
22 | -3= | 1 |
23 | -b2 | 1 |
24 | -encompassing | 1 |
25 | .mothers | 1 |
26 | .once-daily | 1 |
27 | .though | 1 |
28 | /a-v | 1 |
29 | /fvc= | 1 |
30 | /operation | 1 |
31 | /sulfur | 1 |
32 | /very | 1 |
33 | 0.57± | 1 |
34 | 001/16 | 1 |
35 | 1.29- | 1 |
36 | 18.7±11.9 | 1 |
37 | 253-32 | 1 |
38 | 420±1 | 1 |
39 | 513-44 | 1 |
40 | 6.81± | 1 |
41 | 705±1 | 1 |
42 | 925±3 | 1 |
43 | aquillion | 1 |
44 | bupivacain,20ml | 1 |
45 | byori | 1 |
46 | cat-activity | 1 |
47 | celfuroxime | 1 |
48 | chelex-100 | 1 |
49 | ci=- | 1 |
50 | ci=1.4- | 1 |
51 | ci=45-1 | 1 |
52 | citalopram/40 | 1 |
53 | complete/very | 1 |
54 | decylrhodamine | 1 |
55 | dithiazine-3-carbonitriles | 1 |
56 | dithiazines | 1 |
57 | e.def | 1 |
58 | ersus | 1 |
59 | fibrinolysis-rescue | 1 |
60 | fibrinolysis-urgent/elective | 1 |
61 | flb | 1 |
62 | gesundheitsschutz | 1 |
63 | hlas | 1 |
64 | imidacloprid/ | 1 |
65 | isothiazole-3-carbonitriles | 1 |
66 | isothiazoles | 1 |
67 | isothiourea | 1 |
68 | isoxazol-3-yl-aryl-methanones | 1 |
69 | lidocaine/ | 1 |
70 | m/s/week | 1 |
71 | ml+fentanyl | 1 |
72 | mrs5679 | 1 |
73 | mr≥grade | 1 |
74 | na-doped | 1 |
75 | nswsc | 1 |
76 | n₂and | 1 |
77 | o2max= | 1 |
78 | pyrimidine-4-one | 1 |
79 | recipients/35 | 1 |
80 | ropivacaine+fentanyl | 1 |
81 | ropivacaine/1ml | 1 |
82 | trithiazepine-4-carbonitriles | 1 |
83 | tween® | 1 |
84 | usl255/topamax-ratio | 1 |
85 | ∙0.5 | 1 |
86 | ∙3 | 1 |
1 | 'christoph | 1 |
2 | ,13/ | 1 |
3 | -1,3-oxazin-4-one | 2 |
4 | -2-p-tolyloxy-quinoline | 1 |
5 | -3= | 1 |
6 | -b2 | 1 |
7 | -box | 3 |
8 | -bpo | 13 |
9 | -bupivacaine | 9 |
10 | -encompassing | 1 |
11 | -inadequate | 2 |
12 | -v- | 2 |
13 | .mothers | 1 |
14 | .once-daily | 1 |
15 | .though | 1 |
16 | /a-v | 1 |
17 | /bpo | 16 |
18 | /flumethrin | 2 |
19 | /fvc= | 1 |
20 | /moxidectin | 5 |
21 | /operation | 1 |
22 | /sulfur | 1 |
23 | /very | 1 |
24 | 0.57± | 1 |
25 | 0.73- | 2 |
26 | 001/16 | 1 |
27 | 1.29- | 1 |
28 | 18.7±11.9 | 1 |
29 | 253-32 | 1 |
30 | 420±1 | 1 |
31 | 513-44 | 1 |
32 | 6.81± | 1 |
33 | 705±1 | 1 |
34 | 925±3 | 1 |
35 | aquilion | 2 |
36 | aquillion | 1 |
37 | bupivacain,20ml | 1 |
38 | byori | 1 |
39 | cat-activity | 1 |
40 | celfuroxime | 1 |
41 | chelex-100 | 1 |
42 | ci=- | 1 |
43 | ci=1.4- | 1 |
44 | ci=45-1 | 1 |
45 | citalopram/40 | 1 |
46 | complete/very | 1 |
47 | decylrhodamine | 1 |
48 | dithiazine-3-carbonitriles | 1 |
49 | dithiazines | 1 |
50 | e.def | 1 |
51 | ersus | 1 |
52 | female/ | 2 |
53 | fibrinolysis-rescue | 1 |
54 | fibrinolysis-urgent/elective | 1 |
55 | flb | 1 |
56 | gesundheitsschutz | 1 |
57 | hlas | 1 |
58 | imidacloprid/ | 1 |
59 | isothiazole-3-carbonitriles | 1 |
60 | isothiazoles | 1 |
61 | isothiourea | 1 |
62 | isoxazol-3-yl-aryl-methanones | 1 |
63 | lidocaine-medicated | 5 |
64 | lidocaine/ | 1 |
65 | m/s/week | 1 |
66 | mg→15 | 3 |
67 | ml+fentanyl | 1 |
68 | mrs5679 | 1 |
69 | mr≥grade | 1 |
70 | na-doped | 1 |
71 | nswsc | 1 |
72 | n₂and | 1 |
73 | o2max= | 1 |
74 | plus/minus | 20 |
75 | pyrimidin- | 2 |
76 | pyrimidine-4-one | 1 |
77 | recipients/35 | 1 |
78 | ropivacaine+fentanyl | 1 |
79 | ropivacaine/1ml | 1 |
80 | trithiazepine-4-carbonitriles | 1 |
81 | tween® | 1 |
82 | usl255/topamax-ratio | 1 |
83 | vs | 40,765 |
84 | ∙0.5 | 1 |
85 | ∙3 | 1 |
86 | ─ | 20 |
1 | 0.73- | 2 |
2 | ci=1.4- | 1 |
3 | 1.29- | 1 |
4 | ci=- | 1 |
5 | pyrimidin- | 2 |
6 | -v- | 2 |
7 | ,13/ | 1 |
8 | imidacloprid/ | 1 |
9 | female/ | 2 |
10 | lidocaine/ | 1 |
11 | chelex-100 | 1 |
12 | citalopram/40 | 1 |
13 | ci=45-1 | 1 |
14 | 420±1 | 1 |
15 | 705±1 | 1 |
16 | 253-32 | 1 |
17 | -b2 | 1 |
18 | ∙3 | 1 |
19 | 925±3 | 1 |
20 | 513-44 | 1 |
21 | ∙0.5 | 1 |
22 | mg→15 | 3 |
23 | recipients/35 | 1 |
24 | 001/16 | 1 |
25 | 18.7±11.9 | 1 |
26 | mrs5679 | 1 |
27 | -3= | 1 |
28 | /fvc= | 1 |
29 | o2max= | 1 |
30 | isothiourea | 1 |
31 | flb | 1 |
32 | nswsc | 1 |
33 | na-doped | 1 |
34 | lidocaine-medicated | 5 |
35 | n₂and | 1 |
36 | mr≥grade | 1 |
37 | celfuroxime | 1 |
38 | -bupivacaine | 9 |
39 | -2-p-tolyloxy-quinoline | 1 |
40 | decylrhodamine | 1 |
41 | pyrimidine-4-one | 1 |
42 | -1,3-oxazin-4-one | 2 |
43 | -inadequate | 2 |
44 | fibrinolysis-rescue | 1 |
45 | fibrinolysis-urgent/elective | 1 |
46 | e.def | 1 |
47 | -encompassing | 1 |
48 | .though | 1 |
49 | 'christoph | 1 |
50 | byori | 1 |
51 | m/s/week | 1 |
52 | bupivacain,20ml | 1 |
53 | ropivacaine/1ml | 1 |
54 | ropivacaine+fentanyl | 1 |
55 | ml+fentanyl | 1 |
56 | /flumethrin | 2 |
57 | /moxidectin | 5 |
58 | aquilion | 2 |
59 | aquillion | 1 |
60 | /operation | 1 |
61 | usl255/topamax-ratio | 1 |
62 | -bpo | 13 |
63 | /bpo | 16 |
64 | /sulfur | 1 |
65 | hlas | 1 |
66 | isothiazole-3-carbonitriles | 1 |
67 | dithiazine-3-carbonitriles | 1 |
68 | trithiazepine-4-carbonitriles | 1 |
69 | isothiazoles | 1 |
70 | dithiazines | 1 |
71 | isoxazol-3-yl-aryl-methanones | 1 |
72 | .mothers | 1 |
73 | plus/minus | 20 |
74 | ersus | 1 |
75 | vs | 40,765 |
76 | /a-v | 1 |
77 | -box | 3 |
78 | .once-daily | 1 |
79 | /very | 1 |
80 | complete/very | 1 |
81 | cat-activity | 1 |
82 | gesundheitsschutz | 1 |
83 | ─ | 20 |
84 | tween® | 1 |
85 | 6.81± | 1 |
86 | 0.57± | 1 |